Back to UBS Group AG UBS Group AG

TNXPTNXP
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in TONIX PHARMACEUTICALS HLDG C

UBS Group AG holds 231,682 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $3M as of 2026-Q2. The position was increased. TNXP represents 0.0% of UBS Group AG's portfolio.

Current Value

$3M

Current Shares

231,682

Total Value Change

+$2.6M

Total Shares Change

+211,713

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
231,682
0.0%
$3M0.0%$12.76
26
2026-Q1
Increased
231,678
+153.3%
$3.2M0.0%$13.94
43
2025-Q4
Increased
91,459
+77.3%
$1.4M0.0%$15.82
39
2025-Q3
Increased
51,581
+129.6%
$1.2M0.0%$24.76
41
2025-Q2
Increased
22,463
+12.5%
$808,2180.0%$34.89
28
2025-Q1
New
19,969
-
$356,9460.0%$20.17
33

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used